Peripheral Nerve Stimulation and Motor Training in Stroke

Stroke Clinical Trial

Official title:

Peripheral Nerve Stimulation and Motor Training to Enhance Hand Function After Stroke

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02658578
• Other study ID #: 0546/2011
• Secondary ID: R01NS076348
• Status: Completed
• Phase: N/A
• Start date: March 2016
• Est. completion date: March 2021

Study information

• Verified date: November 2020
• Source: University of Sao Paulo General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Cerebrovascular disease is a major cause of disability worldwide. The catastrophic burden of stroke is more dramatic in low- and middle- income countries, and the scarcity of evidence-based rehabilitation interventions represents a major challenge to global health care. Upper limb weakness is frequent after stroke, but there is no universally accepted treatment to effectively improve hand function in patients with moderate and severe motor impairment. These are the patients in deepest need of rehabilitative interventions. This project addresses this important issue, by testing effects of a novel approach. The investigators will non-invasively stimulate peripheral nerves in order to enhance effects of motor training aided by an electrical stimulation device in patients with moderate to severe hand weakness. Our hypothesis is that peripheral nerve stimulation will enhance effects of motor training in patients in the chronic stage after stroke.

Description:

The objective of this protocol is to determine whether a neuromodulation intervention associated with functional electrical stimulation, when combined with task-specific training over several sessions, decreases upper limb motor disability, motor impairment, overall disability and improves quality of life compared to the sham intervention and functional electrical stimulation.

The interventions will consist of three sessions per week, over six weeks, of outpatient functional electrical stimulation of the paretic wrist and task-specific training. In each session, either active peripheral nerve stimulation (PNS) or sham PNS will be applied. Before the first session, patients will be familiarized with the procedures.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 38
• Est. completion date: March 2021
• Est. primary completion date: March 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age, 18 years or older;

• Ischemic or hemorrhagic stroke at least six months before, confirmed by computed tomography or magnetic resonance imaging;

• Moderate to severe motor impairment of an upper limb, defined as a score between 7 and 50 on the Fugl-Meyer Assessment of Sensorimotor Recovery after stroke, a scale with scores for upper limb ranging from 0 (no function) to 66 (normal function);

• Ability to provide written Informed Consent (patient or legal representative);

• Ability to comply with the schedule of interventions and evaluations in the protocol.

Exclusion Criteria:

• Lack of ability to voluntarily activate any active range of wrist extension;

• Anesthesia of the paretic hand;

• Severe spasticity at the paretic elbow, wrist, or fingers, defined as a score of >3 on the Modified Ashworth Spasticity Scale;

• Active joint deformity;

• Uncontrolled medical problems such as end-stage cancer or renal disease;

• Pregnancy;

• Seizures, if current use of drugs that may decrease seizure threshold such as tryciclic antidepressants;

• Pacemakers;

• Other neurological disorders such as Parkinson's disease;

• Psychiatric illness including severe depression;

• Aphasia or serious cognitive deficits that preclude comprehension of the experimental protocol or ability to provide consent;

• Treatment of upper limb spasticity with botulinum toxin within the past three months.

• Lesions that affect the cerebellum or cerebelar/vestibular pathways in the brainstem

Related Conditions & MeSH terms

• Stroke

Intervention

Procedure:
• PNS
Active PNS will be administered by 2 pairs of surface electrodes (cathode proximal). One pair will overly the median and ulnar nerves at the wrist, and the other pair will overly the radial nerve. Trains of electric stimulation will be delivered at 1 Hz by using isolation units connected to a square pulse stimulator. In sham PNS, the median, ulnar and radial nerves will not be actively stimulated.

Locations

Country	Name	City	State
Brazil	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo/Fundação Faculdade de Medicina	São Paulo	SP

Sponsors (4)

Lead Sponsor	Collaborator
University of Sao Paulo General Hospital	Fundação Faculdade de Medicina, National Institute of Neurological Disorders and Stroke (NINDS), The Cleveland Clinic

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Wolf Motor Function Test	The primary outcome will be evaluated before the intervention and 6 weeks after the beginning of the intervention.	6 weeks
Secondary	Motor Activity Log	This questionnaire will be evaluated before the intervention and 3, 6, 10 and 18 weeks after the beginning of the intervention.	18 weeks
Secondary	Active range of motion of wrist extension in the paretic side	This physiological parameter will be evaluated before the intervention and 3, 6, 10 and 18 weeks after the beginning of the intervention.	18 weeks
Secondary	Active range of motion of wrist flexion in the paretic side	This physiological parameter will be evaluated before the intervention and 3, 6, 10 and 18 weeks after the beginning of the intervention.	18 weeks
Secondary	Grasp force in the paretic side	This physiological parameter will be evaluated before the intervention and 3, 6, 10 and 18 weeks after the beginning of the intervention.	18 weeks
Secondary	Grip force in the paretic side	This physiological parameter will be evaluated before the intervention and 3, 6, 10 and 18 weeks after the beginning of the intervention.	18 weeks
Secondary	Fugl-Meyer Assessment of Sensorimotor Recovery	This scale will be evaluated before the intervention and 3, 6, 10 and 18 weeks after the beginning of the intervention.	18 weeks
Secondary	Barthel Index	This scale will be evaluated before the intervention and 3, 6, 10 and 18 weeks after the beginning of the intervention.	18 weeks
Secondary	Stroke Impact Scale	This scale will be evaluated before the intervention and 3, 6, 10 and 18 weeks after the beginning of the intervention.	18 weeks
Secondary	Beck Depression Inventory-short Form	This questionnaire will be evaluated before the intervention and 3, 6, 10 and 18 weeks after the beginning of the intervention.	18 weeks
Secondary	Wolf Motor Function Test	This scale as a secondary outcome will be evaluated before the intervention and 3, 10 and 18 weeks after the beginning of the intervention.	18 weeks
Secondary	Modified Ashworth Scale	This scale will be evaluated before the intervention and 3, 6, 10 and 18 weeks	18 weeks
Secondary	Minimal Clinically Important Difference - Wolf Motor Function Test - time	This outcome will be evaluated at 6, 10 and 18 weeks	18 weeks
Secondary	Minimal Clinically Important Difference - Wolf Motor Function Test - Functional Ability Scale	This outcome will be evaluated at 6, 10 and 18 weeks	18 weeks